Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management

Multiple myeloma (MM) is associated with increased risk of infection, but little is known regarding antibody levels against specific bacteria. We assessed levels of polyclonal immunoglobulin and antibacterial antibodies in patients recruited to the TEAMM trial, a randomised trial of antibiotic proph...

Descripción completa

Detalles Bibliográficos
Autores principales: Chicca, Ilaria J., Heaney, Jennifer L. J., Iqbal, Gulnaz, Dunn, Janet A., Bowcock, Stella, Pratt, Guy, Yong, Kwee L., Planche, Timothy D., Richter, Alex, Drayson, Mark T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642409/
https://www.ncbi.nlm.nih.gov/pubmed/33149136
http://dx.doi.org/10.1038/s41408-020-00370-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642409/
https://www.ncbi.nlm.nih.gov/pubmed/33149136
http://dx.doi.org/10.1038/s41408-020-00370-7

Ejemplares similares